Whitehawk Therapeutics (WHWK) Other Operating Expenses (2010 - 2025)
Whitehawk Therapeutics (WHWK) reported Other Operating Expenses of -$177000.0 for Q3 2025, down 100.2% quarter-over-quarter from $87.4 million in Q1 2025.
Whitehawk Therapeutics (WHWK) Other Operating Expenses (2010 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 9 years of Other Operating Expenses data on file, last reported at -$177000.0 in Q3 2025.
- Other Operating Expenses for Q3 2025 came in at -$177000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$177000.0 (down 100.2% YoY), and the FY2025 annual result was $87.3 million, changed N/A from the prior year.
- Other Operating Expenses eased to -$177000.0 in Q3 2025 per WHWK's latest filing, from $87.4 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $87.4 million in Q1 2025 and troughed at -$177000.0 in Q3 2025.
- A 4-year average of $15.4 million and a median of $656000.0 in 2023 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 99.2% in 2022, then jumped 317.57% in 2023.
- A 4-year view of Other Operating Expenses shows it stood at $74.2 million in 2021, then tumbled by 99.7% to $222000.0 in 2022, then soared by 317.57% to $927000.0 in 2023, then sank by 119.09% to -$177000.0 in 2025.
- Business Quant data shows WHWK's Other Operating Expenses at -$177000.0 in Q3 2025, $87.4 million in Q1 2025, and $927000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -177,000.00 |
| Mar 31, 2025 | 87.44 Mn |
| Dec 31, 2023 | 927,000.00 |
| Sep 30, 2023 | 697,000.00 |
| Jun 30, 2023 | 656,000.00 |
| Mar 31, 2023 | 529,000.00 |
| Dec 31, 2022 | 222,000.00 |
| Sep 30, 2022 | 593,000.00 |
| Jun 30, 2022 | 4.07 Mn |
| Mar 31, 2022 | 179,000.00 |
| Sep 30, 2021 | 74.16 Mn |
| Dec 31, 2019 | 987,210.00 |
| Sep 30, 2019 | -38,810.00 |
| Jun 30, 2019 | 915,094.00 |
| Mar 31, 2013 | -4,806.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,753.00 |
| Jun 30, 2012 | -5,031.00 |
| Mar 31, 2012 | -4,231.00 |
| Dec 31, 2011 | -8,026.00 |